ClinicalTrials.govpublic full text
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
liver cancer, rhabdomyosarcoma, malignant rhabdoid tumor, liposarcoma, wilms tumor, yolk sac tumor, 15.21.gpc3-car t cells, gpc3, glypican, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 915404
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.